Vitskaplege artiklar

Buer AA, Strømme MF, Schmid M, Fismen A-S, Gjestad R, Senneseth M. Frequent psychiatric admissions and the risk of suicide: a prospective total cohort study 2005-2023. https://doi.org/10.1080/08039488.2025.2604656

Ratke I, Torsvik A, Bartz-Johannessen CA, Fathian F, Joa I, Reitan SMK, Løberg EM, Rettenbacher M, Skrede S, Steen VM, Johnsen E, Kroken RA. Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naive schizophrenia spectrum cohort.  https://doi.org/10.1016/j.bbih.2025.100959

Rajen N, Velure HW, Johnsen E, Bjorke-Monsen AL. Impaired folate status in patients with mental disorders. Acta neuropsychiatrica.  https://doi.org/10.1017/neu.2025.1

Hoprekstad GE, Johnsen E, Bartz-Johannessen C, Bjarke JK, Drosos P, Fasmer OB, Gjerde KV, Reitan SK, Skrede S, Sommer IEC, Stabell L, Steen VM, Kroken RA. Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study.  https://doi.org/10.1016/j.bbih.2025.101047

 Fathian F, Divkovic I, Fagerbakke Stromme M, Mykletur A, Kroken RA, Bartz-Johannessen CA et al. Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study. https://doi.org/10.1016/j.bbih.2025.101133  

 Stabell LA, Johnsen E, Kroken RA, Loberg EM, Kjelby E, Joa I et al. Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms.  https://doi.org/10.1016/j.psychres.2026.116948

Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study

Farivar Fathian, Ivana Divkovic, Maria Fagerbakke Strømme, Arnstein Mykletun, Rune A. Kroken, Christoffer A. Bartz-Johannessen, Erik Johnsen

https://doi.org/10.1016/j.bbih.2025.101133

Phenotypic complexities of rare heterozygous neurexin-1 deletions

Michael B Fernando, Yu Fan, Yanchun Zhang, Alex Tokolyi, Aleta N Murphy, Sarah Kammourh, P J Michael Dean , Sadaf Ghorbani, Ryan Onatzevitch, Adriana Pero, Christopher Padilla, Sarah E Williams, Erin K Flaherty, Iya A Prytkov , Lei Cao, David A Knowles , Gang Fang, Paul A Slesinger, Kristen J Brennand 

^{https://www.nature.com/articles/s41586-025-08864-9}

Dynamic convergence of neurodevelopmental disorder risk genes across neurodevelopment. bioRxiv. 2025. The publication is accepted and In Press in the Nature Neuroscience journal.

Garcia MF, Retallick-Townsley K, Pruitt A, Davidson E, Balafkan N, Warrell J, Huang TC, Kibowen A, Chu Z, Dai Y, Fitzpatrick SE, Meng R, Sen A, Cohen S, Livoti O, Khan S, Becker C, E Silva ALT, Liu J, Dossou G, Cheung J, Liu S, Ghorbani S, Deans PJM, Ceciucis M, Emani P, Gao H, Shen H, Gerstein M, Wang Z, Huckins LM, Hoffman EJ, Brennand K. 

doi: 10.1101/2024.08.23.609190

Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study

Gunhhild E Hoprekstad, Erik Johnsen, Christoffer Bartz-Johannessen, Jill Kristin Bjarke, Petros Drosos, Ole Bert Fasmer, Kristian Varden Gjerde, Solveig K Reitan, Silje Skrede, Iris E C Sommer, Lena Stabell, Vidar M Steen, Rune A Kroken

https://doi.org/10.1016/j.bbih.2025.101047

Powell SK, Liao W, O'Shea C, Kammourh S, Ghorbani S, Rigat R, Elahi R, Deans PM, Le DJ, Agarwal P, Seow WQ, Wang KC, Akbaraian S, Brennand. Schizophrenia Risk Mapping and Functional Engineering of the 3D Genome in Three Neuronal Subtypes. bioRxiv. Doi: https://doi.org/10.1101/2023.07.17.549339